ArticleComputer methods and programs in biomedicine2020
Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients.
Article in Computer methods and programs in biomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.
- Preoperative magnetic resonance imaging-radiomics in cervical cancer: a systematic review and meta-analysis.Frontiers in oncology · 2024Pooled it
- Predicting hematologic toxicity in advanced cervical cancer patients using interpretable machine learning models based on radiomics and dosimetrics.BMC cancer · 2025Article
- Machine and Deep Learning for the Diagnosis, Prognosis, and Treatment of Cervical Cancer: A Scoping Review.Diagnostics (Basel, Switzerland) · 2025Review
- Computed tomography-based radiomics modeling to predict patient overall survival in cervical cancer with intensity-modulated radiotherapy combined with concurrent chemotherapy.The Journal of international medical research · 2025Observational
- Artificial intelligence-assisted noninvasive preoperative prediction of lymph nodes metastasis in cervical cancer through a clinical-imaging feature combined strategy.Frontiers in oncology · 2025Article
- Systemic immune-related spleen radiomics predict progression-free survival in patients with locally advanced cervical cancer underwent definitive chemoradiotherapy.BMC medical imaging · 2024Article
- Deep Learning Radiomics Nomogram Based on Multiphase Computed Tomography for Predicting Axillary Lymph Node Metastasis in Breast Cancer.Molecular imaging and biology · 2024Article
- Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy.Scientific reports · 2023Article
- CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy.Frontiers in oncology · 2023Article
- PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features.Molecular imaging and biology · 2022Article
- Exploratory analysis of radiomic as prognostic biomarkers inFrontiers in medicine · 2022Article
- Applying a radiomics-based CAD scheme to classify between malignant and benign pancreatic tumors using CT images.Journal of X-ray science and technology · 2022Article
- Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer.Frontiers in oncology · 2021Article
- Constructing a Classification Model for Cervical Cancer Tumor Tissue and Normal Tissue Based on CT Radiomics.Technology in cancer research & treatmentArticle
- Radiomics Harmonization in Ultrasound Images for Cervical Cancer Lymph Node Metastasis Prediction Using Cycle-GAN.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 2 countries.
Funding
Abstract
BACKGROUND AND
objectiveIn diagnosis of cervical cancer patients, lymph node (LN) metastasis is a highly important indicator for the following treatment management. Although CT/PET (i.e., computed tomography/positron emission tomography) examination is the most effective approach for this detection, it is limited by the high cost and low accessibility, especially for the rural areas in the U.S.A. or other developing countries. To address this challenge, this investigation aims to develop and test a novel radiomics-based CT image marker to detect lymph node metastasis for cervical cancer patients.
methodsA total of 1,763 radiomics features were first computed from the segmented primary cervical tumor depicted on one CT image with the maximal tumor region. Next, a principal component analysis algorithm was applied on the initial feature pool to determine an optimal feature cluster. Then, based on this optimal cluster, the prediction models (i.e., logistic regression or support vector machine) were trained and optimized to generate an image marker to detect LN metastasis. In this study, a retrospective dataset containing 127 cervical cancer patients were established to build and test the model. The model was trained using a leave-one-case-out (LOCO) cross-validation strategy and image marker performance was evaluated using the area under receiver operation characteristic (ROC) curve (AUC).
resultsThe results indicate that the SVM based imaging marker achieved an AUC value of 0.841 ± 0.035. When setting an operating threshold of 0.5 on model-generated prediction scores, the imaging marker yielded a positive and negative predictive value (PPV and NPV) of 0.762 and 0.765 respectively, while the total accuracy is 76.4%.
conclusionsThis study initially verified the feasibility of utilizing CT image and radiomics technology to develop a low-cost image marker to detect LN metastasis for assisting stratification of cervical cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.